Podcasts about sequential

Matthew Cassidy of Partners Wealth Group has just taken the top spot in this year's Barron's Top 150 Advisers List. He offers a unique perspective on what you need to know about advice, and how to deal with an investment market that is clearly at the top of the cycle. Matthew Cassidy of Partners Wealth Group joins Associate Editor - Wealth, James Kirby in this episode. In today's show, we cover: What you should expect from a top financial adviser How to prepare for a sharemarket downturn Sequential risk - The biggest financial threat to the pre-retiree Taking profits off the table See omnystudio.com/listener for privacy information.

Creepy Adaptations: In a belated Halloween episode of Panel Borders, Alex Fitch talks to a trio of creators about their work on creepy adaptations. Graphic novelist, Lucy Sullivan, and film director, Dylan Southern, have worked together on The Thing With Feathers, an adaptation to screen of Max Porter’s award-winning 2015 novella. Lucy has created new […]

The full story behind our 2025 Grid Life Street Mod Championship season. After the struggles of 2024, we came back with a vengeance - 8 events, 5 straight wins, 7 lap records, and the most reliable car in Street Mod.In this extended season recap, Dewey, Dylan, Graham (Boosted Performance Tuning), and Forklift break down everything that happened behind the scenes: building our first sequential transmission, solving the turbo issues at Road Atlanta, the data analysis systems that changed everything, and that incredible rain-soaked victory at Pitt Race.Topics covered:Sequential transmission development and tuning challengesEvery event breakdown from CMP to Pitt RaceTechnical upgrades: suspension geometry, power steering, front diffThe criticism we faced and how we proved everyone wrongBehind-the-scenes logistics and team dynamicsOur systematic approach to data analysis and driver feedbackPlans for 2026: electronic wastegate, motorsport ABS, and morePlus: Terrible steak dinners in castles with Bucky Lasek, windshield explosions, trailer disasters, and why 38°F is the perfect temperature for Pitt Race.This isn't just about winning - it's about the work, the team, and the process that made it possible.#GridLife #TimeAttack #StreetMod #Subaru #Championship #Motorsports

In this episode of Nursing EDge Unscripted, host Dr. Steven Palazzo interviews Dr. LisaMarie Wands about her research on integrating cognitive rehearsal training into nursing education to counteract incivility. Dr. Wands explains how incivility, from dismissive behaviors to overt hostility, harms nursing students and new nurses and contributes to burnout and attrition. Her study, funded by the NLN, used simulation to teach students strategies like pausing and scripted responses when encountering uncivil behavior. Findings revealed that students often struggled to act on these strategies because of their low power in clinical settings, but some reported applying the training once in professional practice. The conversation emphasizes the need for nursing programs to introduce even small-scale training or role-play to prepare students for the realities of incivility in the workplace.Wands, L., McDermott, C., Bernard, N., Wolf, R., & Kimble, L. P. (2025). Implementing Cognitive Rehearsal Training With Nursing Students to Counter Incivility in the Clinical Setting as Students and New Nurses: A Sequential Mixed-Methods Study. Nursing education perspectives, 46(4), 243–245. https://doi.org/10.1097/01.NEP.0000000000001325Dedicated to excellence in nursing, the National League for Nursing is the leading organization for nurse faculty and leaders in nursing education. Find past episodes of the NLN Nursing EDge podcast online. Get instant updates by following the NLN on LinkedIn, Facebook, Instagram, Bluesky, and YouTube. For more information, visit NLN.org.

Watch on YouTube Focusrite #TUNE has delivered 6.6% revenue growth and a near doubling of operating profit in its 12-month interim results, driven by strong performance in Content Creation and robust gross margins. CEO Tim Carroll and CFO Sally McKone discuss product momentum from Scarlett and Sequential, stabilising trends in Audio Reproduction, and how investment in innovation and supply chain flexibility is positioning the group for long-term growth.

SOFA-2, validated in more than 3 million intensive care unit (ICU) patients, incorporates contemporary organ support treatments, showing strong predictive validity for ICU mortality in diverse international settings. Coauthor Mervyn Singer, MD, joins JAMA Associate Editor Christopher W. Seymour, MD, MSc, to discuss. Related Content: Rationale and Methodological Approach Underlying the Development of the Sequential Organ Failure Assessment (SOFA)–2 Score Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score A Revision to Organ Failure Assessment in Critically Ill Patients

Our Special Guest this week is Kathryn Ventham, Senior Director at Twenty5 Planning. Kathryn is a Chartered Town Planner with 25 years experience specialising in strategic land promotion and mixed use/residential led development. She is a leading advisor in respect of matters relating to flood risk sequential testing - working with Counsel and government bodies in this regard.Latest News Update since we were last on the air.A Court of Appeal Decision related to the Bell Hotel in Epping. The appeal was brought by Somani Hotels Limited against Epping Forest District Council. At the previous hearing on 15 August 2025 before the judge, the Council sought an interim injunction requiring Somani to stop using or permitting the use of the Hotel for accommodating asylum seekers or for using the Hotel for any use other than as a hotel until the trial of the claim.A Decision of the SoS regarding an expansion of Sky Studios in Elstree including a film and television production studio (use Class E(g)(ii)) with ancillary floorspace, backlot, 7 new access arrangements, car parking, landscaping, infrastructure and associated works. The appeal was made by Sky Studios Ltd and Legal and General Investment Managment against a prior refusal by Hertsmere Borough Council. A Decision of the SoS involving planning permission for demolition and preparation works on the site of Brighton Gasworks brought by St William Homes LLP. Works outlined included: a comprehensive mixed-use redevelopment comprising site preparation and enabling works, demolition of existing buildings and structures; provision of new buildings comprising residential use (Use Class C3) and flexible non-residential floorspace (Use Class E), new private and communal amenity space. A Decision of the SoS refusing planning permission for 148 dwellings in Reading, Berkshire. The appeal was made by Wates Developments Ltd against a previous refusal by Wokingham Borough Council. This was a second inquiry after a previous grant of permission was quashed by the High Court. Issues raised in the appeal include: the effect of the development upon the character and appearance of the countryside; the effect upon surface drainage; the safety and wellbeing of future residents of the proposed development, and the wider public, with regard to the proximity of the Atomic Weapons Establishment site at Burghfield (AWE(B)); and the future capability and capacity of AWE(B) to operate effectively.Episode resources can be found on our website below:⁠hwgpnfy.com

Midjourney Fast Hours — Episode 51: “Sora 2, Veo 3 & The AI Video Gold Rush”Drew and Rory crawl out of their creative caves after a month-long “break” (read: total burnout) and immediately get smacked in the face by Sora 2, Veo 3, and Midjourney Style Explorer updates that make everything they said last episode obsolete.They break down what's actually working in Sora 2 (full edits, audio, dialogue, even IP?), why Veo 3 can't seem to go fast anymore, and how keyframes are quietly becoming the holy grail of AI video.Expect rants about IP chaos, Mr. Rogers cameos, and why OpenAI's guerilla launch strategy might be the smartest marketing move of 2025.It's equal parts therapy session, tech panic, and creative caffeine rush — exactly how they like it.Keywords: Sora 2 update, Google Veo 3 review, Midjourney V8, AI video generation tools, Luma AI, keyframes, AI video editing, AI marketing trends 2025, generative video, Style Explorer Midjourney---⏱️ Midjourney Fast Hour00:00 – Intro + return from creative hibernation00:42 – Sora 2 drops: “the floodgates just opened”01:27 – Sora 2's new tricks: editing, sound, dialogue, and IP02:17 – Veo 3 vs Sora 2 vs Ray 303:20 – Rory's South Park AI episode + the “bar-only” friend05:00 – Why dedicated AI-only spaces actually matter05:48 – Remix culture, Mr. Rogers AI, and the rise of comedic timing07:00 – The “Remix” button, mass adoption, and kids using Sora08:43 – The IP gray area: Minecraft meets Mr. Rogers09:43 – Cameos, access codes, and mobile vs desktop creation12:25 – Sequential storytelling: AI understands chronology now13:29 – Toyota ads, guerrilla launches, and OpenAI's flood strategy15:00 – IP risk vs reward — how far can brands push it18:00 – AI performance comparisons23:00 – Fight scenes, motion control, and why keyframes matter27:50 – Workflow troubleshooting and micro-decision fatigue34:50 – Too many tools? Runway, Aleph, and the Weavy advantage35:45 – Shout-out to Weavy + tool consolidation predictions36:00 – Higgsfield pivots, Pika memes, and the marketing gap37:00 – Visual Electric's acquisition and the coming consolidation wave38:20 – Midjourney updates: Style Explorer, Smart Search, and new unlocks40:30 – Playing with EXP mode + hidden color/style refinements42:30 – Style Finder, Style Creator, and mood-board personalization43:57 – Style ranking feature + --r 40 nostalgia meltdown46:00 – Midjourney V8 speculation & dataset rumors50:30 – Google's product chaos: Gemini, Nano Banana, Flow, and Veo 353:00 – Why Google can fail (and still win)55:10 – ChatGPT's image text features & the next AI video wave59:30 – The Weavy renaissance and workflow automation discussion1:02:00 – New creative problems worth solving1:06:00 – Why “easy” AI creation still stings for creatives1:08:30 – Closing banter + “hit the button” outro

Robaux's serving pie, Teenage Engineering's cooking dub, and Sequential's back with poly aftertouch.

Inspired by the Twentieth Century: Alex Fitch looks at the work of cartoonists influenced by the culture of the Twentieth Century. In a Q and A recorded at the Lakes International Comic Art Festival, artist Juanjo Guarnido discusses his much loved anthropormophic graphic novel series Blacksad, and in a conversation recorded at Cartoon County, Digital […]

Cunningcast is back and Tony is kicking off his new series with one of his favourite subjects, Stonehenge, where new discoveries show that once again this ancient site is throwing up new evidence. Tony has invited his old friend, leading archaeologist Mike Parker Pearson, to discuss the Altar Stone's Scottish origins and its implications for understanding the monument's significance.Also joining the chat is top geologist Jane Evans, whose new research has revealed the fascinating story of an ancient cow's journey from Wales to Stonehenge. Through isotope analysis, Jane has uncovered insights about the Stonehenge cow's diet and origins, leading to broader implications about our ancient communities and their interactions.Hosted by Sir Tony Robinson | Instagram @sirtonyrobinsonProducer: Melissa FitzGerald With Mike Parker Pearson Professor of British Later Prehistory, University College London. He specialises in British and European prehistory from the Neolithic to the Iron Age; Stonehenge and the British Neolithic; the Beaker people of Bronze Age Europe; the archaeology of the Western Isles (Outer Hebrides); the archaeology of Madagascar and the Indian Ocean; the archaeology of death and burial; public archaeology and heritage. Parker Pearson, M. 2023. Stonehenge: a brief history. London: Bloomsbury Publishing | https://www.bloomsburycollections.com/monograph?docid=b-9781350192263 Parker Pearson, M., Bevins, R.I., Bradley, R., Ixer, R.E., Pearce, N.J.G. and Richards, C. 2024. ‘Stonehenge and its Altar Stone: the significance of distant stone sources'. Archaeology International 27: 113–37 | https://journals.uclpress.co.uk/ai/article/id/3293/ Professor Jane Evans Geologist whose early career focused on using isotope methods for dating rocks. She later turned her expertise toward archaeology, pioneering the use of isotopes to study past human migration. Now retired, she holds honorary professorships in archaeology at the Universities of Nottingham and Leicester and is an Honorary Research Associate at the British Geological Survey. Throughout her career, Jane has used the chemical signatures preserved in human remains to reveal where people came from and how they moved across landscapes. Her work has been central to major discoveries — from uncovering stories at Stonehenge and identifying Viking remains near Weymouth, to contributing to the investigation of King Richard III. Evans, J., Pashley, V., Wagner, D., Savickaite, K., Buckley, M., Madgwick, R. and Parker Pearson, M. In press. Sequential multi-isotope sampling through a Bos taurus tooth to assess comparative sources in strontium and lead. Journal of Archaeological Science | https://www.sciencedirect.com/science/article/pii/S0305440325001189Follow us:Instagram @cunningcastpod | X @cunningcastpod | YouTube @cunningcast Hosted on Acast. See acast.com/privacy for more information.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WMD865. CME credit will be available until August 20, 2026.At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Multiple Myeloma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WMD865. CME credit will be available until August 20, 2026.At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Multiple Myeloma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WMD865. CME credit will be available until August 20, 2026.At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Multiple Myeloma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WMD865. CME credit will be available until August 20, 2026.At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Multiple Myeloma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WMD865. CME credit will be available until August 20, 2026.At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Multiple Myeloma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WMD865. CME credit will be available until August 20, 2026.At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Multiple Myeloma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

Comic Book Team-Ups: Alex Fitch talks to a trio of creators about their collaborative work. Matt Wakeham discusses writing and compiling the new coffee table book of Phoo Action, a cult comic by Jamie Hewlett that Wakeham wrote the second series of and adapted for television, which was originally serialised in The Face magazine. And […]

As an independent musician, diving into the world of MIDI controllers and studio gear can feel intimidating, especially if you're unsure where to start or which tools best suit your creative process. In this episode, Xylo chats with Alex Godfrey, Product Specialist at the Focusrite Group, about what MIDI controllers actually are, how they work, and how to choose the right one for your music.With over 10 years at Focusrite and hands-on experience representing brands like Novation, Sequential, Oberheim, Focusrite, Adam Audio, and Sonnox, Alex breaks down the essentials of MIDI technology in a clear and practical way. From testing music tech as part of Focusrite's QA Engineering team to producing experimental tracks as Psychedalex, he brings both technical expertise and creative insight. Whether you're just setting up your first home studio or looking to expand your gear, this conversation will help you make confident, informed choices.Distrokid has kindly offered all MPW listeners a 30% discount off the first year of their annual subscription! Use the following link to redeem the discount: http://distrokid.com/vip/mpw

Clay Stephens of 6XD Gearbox joins us to teach us a bit about their product, sequential transmissions, the creation of the 6XD standard gearbox, the XTD gearbox, and the MTX transaxle. In addition to a bit about himself as well. High Performance Academy: https://hpcdmy.co/Minnoxide Use code "MINNOX" for 55% off ANY course Use Code "MINVIP" for $300 of the MINVIP Package Tuned By Shawn: https://www.tunedbyshawn.com Code "Minnoxide" for 5% off! Sure Things Logistics: https://www.surethinglogistics.net MORE BIGGER Turbo T-Shirts:  https://www.minnoxide.com/products/more-bigger-t-shirt

In this week's episode, we'll learn more about how exogenous CD19 stimulation affects CAR T-cell persistence in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy; new algorithms that incorporate sequential rapid immune-assays, intended to improve diagnosis of heparin-induced thrombocytopenia, and resource-adaptive survival prediction models to help guide management of patients with chronic myelomonocytic leukemia.Featured Articles:Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALLSequential combinations of rapid immunoassays for prompt recognition of heparin-induced thrombocytopeniaBLAST: a globally applicable and molecularly versatile survival model for chronic myelomonocytic leukemia

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until August 10, 2026.The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from GSK, Johnson & Johnson, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until August 10, 2026.The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from GSK, Johnson & Johnson, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until August 10, 2026.The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from GSK, Johnson & Johnson, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until August 10, 2026.The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from GSK, Johnson & Johnson, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until August 10, 2026.The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from GSK, Johnson & Johnson, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until August 10, 2026.The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from GSK, Johnson & Johnson, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

A quick run-through of the plot elements in the first half of Blake's The Four Zoas. But then a discussion of why such a synopsis is only a useful fiction or scaffolding. The poem describes a higher order of reality falling into the lower one and becoming it. Things are metamorphosing into their fallen forms, the forms we call ordinary reality. This is a fall from a circumference to an alienated center.

The revelation that shattered systems thinking: Replacing every combustion car with electric vehicles improves urban efficiency by only 6%—revealing why isolated optimizations fail in complex ecosystems.Dr. Parfait Atchadé from MIT Media Lab discovered this through quantum-enhanced urban modeling in Boston's Kendall Square. His breakthrough: humanized AI agents with emotional architectures that "live" in virtual cities for decades of compressed time, then vote on configurations—exposing the systematic failure of single-variable optimization. Paradigm Shifts:→ The Single-Solution Trap: Complex systems require the vast majority of improvements from interconnected changes—individual optimizations create illusion of progress while missing systemic impact→ Quantum Superposition Planning: Test multiple city configurations simultaneously rather than sequential scenarios—compress 40 years of urban experience into months of simulation→ Agents with Feelings: AI agents embedded with emotional models (joy, fear, anger, sadness) provide qualitative experience data impossible to capture from human stakeholders→ Portfolio Voting Revolution: Beyond binary decisions—split voting percentages across options like investment portfolios, enabling nuanced collective optimization→ Traditional systems modeling: Sequential scenario testing vs. Quantum approach: Parallel reality simulation with dramatic efficiency gainsThe Innovation: Humanized Agent-Based Modeling (h-ABM) creates digital beings with memory, perception, and emotional responses that navigate virtual systems, accumulating experiences and providing stakeholder insights traditional analytics cannot capture.Strategic Application: Any complex ecosystem requiring multi-stakeholder optimization—from organizational transformation to supply chain design—can leverage quantum-enhanced modeling with emotionally-intelligent agents.Strategic Reframe: The most adaptive ecosystems will shift from asking "How do we optimize individual components?" to understanding: "How do we architect systems where quantum-enhanced agents can help us reveal the hidden interdependencies that single-solution approaches systematically miss?"#EcosystemicFutures #QuantumComputing #SystemsThinking #UrbanPlanning #MIT #ComplexSystems #AgentBasedModelingGuest: Dr. Parfait Atchadé, Research Affiliate, MIT Media Lab | Strategic Business Officer, Lighthouse DIGHost: Marco Annunziata, Co-founder, Annunziata & Desai AdvisorsSeries Hosts: Vikram Shyam, Lead Futurist, NASA Glenn Research Center Dyan Finkhousen, Founder & CEO, Shoshin WorksEcosystemic Futures is provided by NASA Convergent Aeronautics Solutions Project in collaboration with Shoshin Works.

This episode features Travis Parker, Lisa Maye, and Ashley Krider from Policy Research Associates, who discuss the Sequential Intercept Model (SIM) and its role in driving systems change for people with behavioral health conditions. Data Points is an ongoing podcast series produced by Policy Research that discusses research for social change. Episode Transcript: https://www.prainc.com/wp-content/uploads/2025/07/DataPoints-SIM-Transcript-FINAL-508.pdf Resources: -Sequential Intercept Model Mapping Workshops: https://smtc.prainc.com/services/sequential-intercept-model-mapping-workshops/ -Sequential Intercept Model: https://prainc.com/sim - Incorporating 988 Into the SIM: A Nationwide Opportunity for Deflection From Law Enforcement Contact at Intercept 0: https://www.prainc.com/incorporating-988-into-sim-nationwide-opportunity-deflection-law-enforcement-contact-intercept-0/ - Exploring Intercept 0 of the Sequential Intercept Model: The Earliest Off-Ramp on the Road Toward Criminal Legal System Involvement: https://www.prainc.com/intercept-0-sequential-intercept-model/ - Brief Jail Mental Health Screen: https://www.prainc.com/product/brief-jail-mental-health-screen/ -Systems Mapping and Training Center: smtc.prainc.com/ -PRA eNews Sign Up: signup.e2ma.net/signup/1834746/1788027/

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/IPCE information, and to apply for credit, please visit us at PeerView.com/HAZ865. CME/NCPD/IPCE credit will be available until July 17, 2026.The BCMA Playbook in Multiple Myeloma: Mastering Sequential Strategies With Bispecific Antibodies and CAR-T Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UMD865. CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE credit will be available until July 10, 2026.The Road Ahead for Enhanced Sequential Care in CLL—Updates With Targeted Therapy In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UMD865. CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE credit will be available until July 10, 2026.The Road Ahead for Enhanced Sequential Care in CLL—Updates With Targeted Therapy In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/IPCE information, and to apply for credit, please visit us at PeerView.com/HAZ865. CME/NCPD/IPCE credit will be available until July 17, 2026.The BCMA Playbook in Multiple Myeloma: Mastering Sequential Strategies With Bispecific Antibodies and CAR-T Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UMD865. CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE credit will be available until July 10, 2026.The Road Ahead for Enhanced Sequential Care in CLL—Updates With Targeted Therapy In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/IPCE information, and to apply for credit, please visit us at PeerView.com/HAZ865. CME/NCPD/IPCE credit will be available until July 17, 2026.The BCMA Playbook in Multiple Myeloma: Mastering Sequential Strategies With Bispecific Antibodies and CAR-T Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UMD865. CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE credit will be available until July 10, 2026.The Road Ahead for Enhanced Sequential Care in CLL—Updates With Targeted Therapy In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/IPCE information, and to apply for credit, please visit us at PeerView.com/HAZ865. CME/NCPD/IPCE credit will be available until July 17, 2026.The BCMA Playbook in Multiple Myeloma: Mastering Sequential Strategies With Bispecific Antibodies and CAR-T Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/IPCE information, and to apply for credit, please visit us at PeerView.com/HAZ865. CME/NCPD/IPCE credit will be available until July 17, 2026.The BCMA Playbook in Multiple Myeloma: Mastering Sequential Strategies With Bispecific Antibodies and CAR-T Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UMD865. CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE credit will be available until July 10, 2026.The Road Ahead for Enhanced Sequential Care in CLL—Updates With Targeted Therapy In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ABM865. CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE credit will be available until July 24, 2026.Staying on Track Toward Better CLL Outcomes: Delivering Effective Sequential Care Guided by Real-World Experience In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ABM865. CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE credit will be available until July 24, 2026.Staying on Track Toward Better CLL Outcomes: Delivering Effective Sequential Care Guided by Real-World Experience In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ABM865. CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE credit will be available until July 24, 2026.Staying on Track Toward Better CLL Outcomes: Delivering Effective Sequential Care Guided by Real-World Experience In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ABM865. CME/MOC/EBAH/NCPD/CPE/AAPA/IPCE credit will be available until July 24, 2026.Staying on Track Toward Better CLL Outcomes: Delivering Effective Sequential Care Guided by Real-World Experience In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

Disjointed Or Sequential? / Luke 9:51-62Get the episode here.                                                                                      

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

Vertical Integration: NEOM's Ground-Up Approach to eVTOL Ecosystems

In this special episode, Dr. Shaji Kumar from the Mayo Clinic speaks with Blood editor Dr. Laurie Sehn on a paper recently published in Blood, "Eliminating the Need for Sequential Confirmation of Response in Multiple Myeloma". The findings demonstrate eliminating the need for sequential confirmation of response in multiple myeloma. The study, involving 583 episodes of progression, found that simultaneous confirmation of disease progression using two different markers (e.g., serum protein electrophoresis and serum free light chain assay) was 98% accurate, compared to 82% for sequential confirmation. This suggests that simultaneous confirmation could improve clinical trial accuracy and reduce false censoring. The International Myeloma Working Group is set to revise its response criteria to incorporate these findings, potentially simplifying disease assessment and reducing the need for multiple blood draws.